Parkinson's Disease

Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.

Feb 18, 2024

The brain renin-angiotensin system (RAS) has been related to dopaminergic degeneration, and high expression of the angiotensin II (AngII) type 1 receptor (AT1) gene is a marker of the most vulnerable ...

Automatic speech-based assessment to discriminate Parkinson's disease from essential tremor with a cross-language approach.

Feb 18, 2024

Parkinson's disease (PD) and essential tremor (ET) are prevalent movement disorders that mainly affect elderly people, presenting diagnostic challenges due to shared clinical features. While both diso...

Coupled Activation of the Hyperdirect and Cerebellothalamic Pathways with Zona Incerta Deep Brain Stimulation.

Feb 07, 2024

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or ventral intermediate nucleus (VIM) are established targets for the treatment of Parkinson's disease (PD) or essential tremor (ET), resp...

Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson's disease subtypes.

Nov 15, 2023

Research shows that individuals with Parkinson's disease (PD) who have a postural instability and gait difficulties (PIGD) subtype have a faster disease progression compared to those with a tremor dom...

Role of mitophagy in ocular neurodegeneration.

Nov 15, 2023

Neurons in the central nervous system are among the most metabolically active cells in the body, characterized by high oxygen consumption utilizing glucose both aerobically and anaerobically. Neurons ...

Differential effects of dopamine receptor agonists ropinirole and quinpirole on locomotor and anxiolytic behaviors in larval zebrafish (Danio rerio): A role for the GABAergic and glutamate system?

May 22, 2023

Zebrafish are frequently used as a vertebrate model to elucidate toxicological and pharmacological mechanisms of action in the central nervous system. Pharmacological studies demonstrate that dopamine...

Continuous Levodopa/Carbidopa Infusion Shows Favorable Efficacy, Safety

May 15, 2023

Continuous levodopa/carbidopa infusion had a good safety profile and was well-tolerated longer-term in patients with Parkinson's disease and motor fluctuations. Continuous levodopa/carbidopa in...

People with Early Onset Parkinson's Disease: Empowered to Improve Care.

May 15, 2023

Patient organizations play an ever-growing role in modern societies by providing organized resources for patients and care partners. Importantly, patient organizations enable patients to define and sh...

Microtubule acetylation dyshomeostasis in Parkinson's disease.

May 08, 2023

The inter-neuronal communication occurring in extensively branched neuronal cells is achieved primarily through the microtubule (MT)-mediated axonal transport system. This mechanistically regulated sy...

Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy.

May 01, 2023

The precise segmentation of atrophic structures remains challenging in neurodegenerative diseases. We determined the performance of a Deep Neural Patchwork (DNP) in comparison to established segmentat...

NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.

Apr 10, 2023

NPC1 encodes a lysosomal protein involved in cholesterol transport. Biallelic mutations in this gene may lead to Niemann-Pick disease type C (NPC), a lysosomal storage disorder. The role of NPC1 in al...

15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson's disease patient with Parkin gene mutation: a case report.

Apr 10, 2023

Parkinson's Disease (PD) patients with Parkin gene (PRKN) mutations show good response to subthalamic deep brain stimulation (STN-DBS). Currently, the longest follow-up available of these patients is ...

Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.

Mar 27, 2023

The formation of aggregates due to protein misfolding is encountered in various neurodegenerative diseases. α-Synuclein (α-Syn) aggregation is linked to Parkinson's disease (PD). It is one of the mo...

The predictive relationships between advanced dynamic balance and physical activity/quality of life in Parkinson's disease.

Mar 13, 2023

Gait and balance problems commonly occur in Parkinson's disease (PD). However, balance tasks with only one performance objective (e.g., sit-to-stand) may not be sufficient, compared to dual motor task...

GSK-3β: An Exuberating Neuroinflammatory Mediator in Parkinson's Disease.

Mar 13, 2023

Neuroinflammation is a critical degradative condition affecting neurons in the brain. Progressive neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease (PD) have been strong...

Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases.

Feb 27, 2023

This chapter utilizes genomic concepts and evolutionary perspectives to further understand the possible links between typical brain aging and neurodegenerative diseases, focusing on the two most preva...

in Patients with Parkinson's Disease: A Pilot Study.

Feb 20, 2023

(L.) Wettst. could be of interest in the control of symptoms of Parkinson's disease, but clinical evidence of its efficacy is lacking. This clinical trial assessed the effects of an extract of on pa...

The deficiency of Maged1 attenuates Parkinson's disease progression in mice.

Feb 13, 2023

Melanoma-associated antigen D1 (Maged1) has critical functions in the central nervous system in both developmental and adult stages. Loss of Maged1 in mice has been linked to depression, cognitive dis...

Sleep and wakefulness disturbances in Parkinson's disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia.

Jan 30, 2023

Sleep disorders (SDs) are common non-motor symptoms of Parkinson's disease (PD) with wide variability in their prevalence rates. The etiology of SDs in PD is multifactorial because the degenerative pr...

Carnosic acid attenuated cytochrome c release through the mitochondrial structural protein Mic60 by PINK1 in SH-SY5Y cells.

Jan 30, 2023

Mitochondrial dysfunction has been implicated in Parkinson's disease. Mic60 is a critical component of mitochondrial crista remodeling and participates in maintaining mitochondrial structure and funct...